XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities    
Net loss $ (3,745,543) $ (8,594,581)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 48,230 67,606
Stock-based compensation expense 737,284 807,523
Interest expense 0 37,440
Deferred income tax benefit 0 (21,333)
Changes in current assets and liabilities:    
Prepaid expenses and other current assets (118,767) (295,246)
Accounts payable and accrued liabilities (860,043) (2,174,951)
Other assets 0 (20,743)
Net cash used in operating activities (3,938,839) (10,194,285)
Investing activities    
Purchases of property and equipment 0 (122,853)
Purchases of mineral rights and properties 0 (30,778)
Net cash used in investing activities 0 (153,631)
Financing activities    
Proceeds from sale of common stock on at-the market ("ATM") program, net of issuance costs 7,316,230 (92,500)
Proceeds from common stock offering, net of issuance costs 32,684,881 0
Proceeds from exercise of options 19,200 0
Proceeds from exercise of warrants 1,622,500 0
Payments of income taxes on performance stock units ("PSUs"), restricted stock units ("RSUs") and shares issued for compensation (507,594) 0
Net cash provided by (used in) financing activities 41,135,217 (92,500)
Net change in cash and cash equivalents 37,196,378 (10,440,416)
Cash and cash equivalents, beginning of period 9,408,270 25,548,373
Cash and cash equivalents, end of period 46,604,648 15,107,957
Non-cash investing and financing activities    
Amortization of deferred ATM offering costs offset against additional paid-in capital (37,293) (39,657)
Common stock issued for accrued bonuses 113,958 0
Common stock issued for purchase of mineral rights and properties $ 0 $ 1,351,747